Related references
Note: Only part of the references are listed.Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Hikmat Abdel-Razeq et al.
BMC CANCER (2018)
High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
Al-Joharah Alhuqail et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families
Aouatef Riahi et al.
BREAST CANCER (2017)
Perceptions of Arab men regarding female breast cancer screening examinations-Findings from a Middle East study
Tam Truong Donnelly et al.
PLOS ONE (2017)
Family history and risk of breast cancer: an analysis accounting for family structure
Hannah R. Brewer et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Molecular genetics complexity impeding research progress in breast and ovarian cancers
Ishita Gupta et al.
MOLECULAR AND CLINICAL ONCOLOGY (2017)
Tumor characteristics and prognosis in familial breast cancer
G. Arpino et al.
BMC CANCER (2016)
Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis
Rong Bu et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
BRCA1 and BRCA2 Mutations in Ethnic Lebanese Arab Women With High Hereditary Risk Breast Cancer
Nagi S. El Saghir et al.
ONCOLOGIST (2015)
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing
Priyanka Sharma et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias
James P. Hunter et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
Arab Women's Breast Cancer Screening Practices: A Literature Review
Tam Truong Donnelly et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study
Sang-Ah Han et al.
FAMILIAL CANCER (2013)
Mutation Screening of the BRCA1 Gene in Early Onset and Familial Breast/Ovarian Cancer in Moroccan Population
Abdelilah Laraqui et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
Breast cancer in Arab populations: molecular characteristics and disease management implications
Lotfi Chouchane et al.
LANCET ONCOLOGY (2013)
Breast cancer among Yemeni women using the National Oncology Centre Registry 2004-2010
S. El-Zaemey et al.
CANCER EPIDEMIOLOGY (2012)
BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: Novel mutations and unclassified variants
Amal Tazzite et al.
GYNECOLOGIC ONCOLOGY (2012)
BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases
Nancy Uhrhammer et al.
International Journal of Medical Sciences (2012)
Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement
Damian Hoy et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Hereditary breast cancer in Middle Eastern and North African (MENA) populations: identification of novel, recurrent and founder BRCA1 mutations in the Tunisian population
Wijden Mahfoudh et al.
MOLECULAR BIOLOGY REPORTS (2012)
Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon
Nadine Jalkh et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
BRCA in breast cancer: ESMO Clinical Practice Guidelines
J. Balmana et al.
ANNALS OF ONCOLOGY (2010)
Presymptomatic breast cancer in Egypt: role of BRCA1 and BRCA2 tumor suppressor genes mutations detection
Safinaz S. Ibrahim et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for Hereditary Breast-Ovarian Cancer
Michael J. Hall et al.
CANCER (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
Alessandro Liberati et al.
PLOS MEDICINE (2009)
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
Kokichi Sugano et al.
CANCER SCIENCE (2008)
A quality-effects model for meta-analysis
Suhail A. R. Doi et al.
EPIDEMIOLOGY (2008)
A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer
Luna Kadouri et al.
BMC CANCER (2007)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany
U Hamann et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2003)
Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer
N Loman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
